Can the therapeutic choice and efficacy of more advanced treatments, including Deep brain Stimulation (DBS) or Continuous Apomorphine Perfusion (CAP), to improve quality of life of people with Parkinson’s disease (PwP) be predicted by personality assessments before they are implemented? Data indicate that different personality dimensions may possibly direct towards specific individualized choice of DBS or CAP for the best possible therapeutic response.